Do reproductive history and information given through genetic counselling influence patients' decisions on mosaic embryo transfer?


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
12 2022
Historique:
revised: 04 10 2022
received: 16 03 2022
accepted: 10 11 2022
pubmed: 14 11 2022
medline: 16 12 2022
entrez: 13 11 2022
Statut: ppublish

Résumé

To assess patients' and embryonic characteristics that may have an influence on the decision to transfer a mosaic embryo. Single centre retrospective cohort study including 1247 PGT-A cycles. Demographic and clinical factors associated with a decision to transfer a mosaic embryo were studied. Female age, number of previous cycles, previous availability of euploid embryos, history of miscarriages and parity as well as percentage of mosaicism, type of anomaly and chromosome risk were studied in relation to decision-making. Outcomes after mosaic embryo transfer were assessed. To date, in 7.9% of cycles (99/1247), patients have had to make a decision on the fate of their mosaic embryos. In 23.2% of cycles (23/99), patients decided to transfer. In most cases (79.8%; 79/99), patients underwent genetic counselling before the decision. None of the variables analysed were associated with the patients' decision, although parity and the high-degree mosaicism (>50%) seemed to be negatively associated with the decision to transfer (18.2% vs. 29.8%, p = 0.294; 10% vs. 32.2%, p = 0.052). Neither reproductive history nor information on mosaic embryo characteristics through counselling seems to be determinative for patients when deciding to transfer a mosaic embryo. Promising and increasing data on clinical outcomes after mosaic embryo transfer will be of utmost importance to soften risk perception regarding mosaic embryos and give a better, simplified and more evidence-based counselling.

Identifiants

pubmed: 36371619
doi: 10.1002/pd.6267
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1650-1657

Informations de copyright

© 2022 John Wiley & Sons Ltd.

Références

Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med. 2015;373(21):2089-2090. https://doi.org/10.1056/nejmc1500421
Maxwell SM, Colls P, Hodes-Wertz B, et al. Why do euploid embryos miscarry? A case-control study comparing the rate of aneuploidy within presumed euploid embryos that resulted in miscarriage or live birth using next-generation sequencing. Fertil Steril. 2016;106(6):1414-1419.e5. https://doi.org/10.1016/j.fertnstert.2016.08.017
Munné S, Spinella F, Grifo J, et al. Clinical outcomes after the transfer of blastocysts characterized as mosaic by high resolution Next Generation Sequencing-further insights. Eur J Med Genet. 2019;63(2):103741. https://doi.org/10.1016/j.ejmg.2019.103741
Spinella F, Fiorentino F, Biricik A, et al. Extent of chromosomal mosaicism influences the clinical outcome of in vitro fertilization treatments. Fertil Steril. 2018;109(1):77-83. https://doi.org/10.1016/j.fertnstert.2017.09.025
Victor AR, Tyndall JC, Brake AJ, et al. One hundred mosaic embryos transferred prospectively in a single clinic: exploring when and why they result in healthy pregnancies. Fertil Steril. 2019;111(2):280-293. https://doi.org/10.1016/j.fertnstert.2018.10.019
Grati FR, Gallazzi G, Branca L, Maggi F, Simoni G, Yaron Y. An evidence-based scoring system for prioritizing mosaic aneuploid embryos following preimplantation genetic screening. Reprod Biomed Online. 2018;36(4):442-449. https://doi.org/10.1016/j.rbmo.2018.01.005
Viotti M, Victor AR, Barnes FL, et al. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Fertil Steril. 2021;115(5):1212-1224. https://doi.org/10.1016/j.fertnstert.2020.11.041
COGEN. CoGEN [WWW Document]; 2018. URL. Accessed October 19, 2021. https://ivfworldwide.com/cogen/general/cogen-statement.html
Leigh D, Cram DS, Rechitsky S, et al. PGDIS position statement on the transfer of mosaic embryos 2021. Reprod Biomed Online. 2022;45(1):19-25. https://doi.org/10.1016/j.rbmo.2022.03.013
Bolton H, Graham SJL, Van der Aa N, et al. Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential. Nat Commun. 2016;7(1):11165. https://doi.org/10.1038/ncomms11165
Malvestiti F, Agrati C, Grimi B, et al. Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis. Prenat Diagn. 2015;35(11):1117-1127. https://doi.org/10.1002/pd.4656
Besser AG, Mounts EL. Counselling considerations for chromosomal mosaicism detected by preimplantation genetic screening. Reprod Biomed Online. 2017;34(4):369-374. https://doi.org/10.1016/j.rbmo.2017.01.003
Besser AG, McCulloh DH, Grifo JA. What are patients doing with their mosaic embryos? Decision making after genetic counseling. Fertil Steril. 2019;111(1):132-137.e1. https://doi.org/10.1016/j.fertnstert.2018.10.001
Martinez F, Rodriguez I, Devesa M, Buxaderas R, Gomez MJ, Coroleu B. Should progesterone on the human chorionic gonadotropin day still be measured? Fertil Steril. 2016;105(1):86-92. https://doi.org/10.1016/j.fertnstert.2015.09.008
Coll L, Parriego M, Mateo S, et al. Prevalence, types and possible factors influencing mosaicism in IVF blastocysts: results from a single setting. Reprod Biomed Online. 2021;42(1):55-65. https://doi.org/10.1016/j.rbmo.2020.09.025
Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online. 2005;11(3):300-308. https://doi.org/10.1016/s1472-6483(10)60837-1
Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion. Fertil Steril. 2020;114(2):246-254.
Álvarez M, Gaggiotti-Marre S, Martínez F, et al. Individualised luteal phase support in artificially prepared frozen embryo transfer cycles based on serum progesterone levels: a prospective cohort study. Hum Reprod. 2021;36(6):1552-1560. https://doi.org/10.1093/humrep/deab031
Coroleu B, Barri PN, Carreras O, Martinez F, Veiga A, Balasch J. The usefulness of ultrasound guidance in frozen-thawed embryo transfer: a prospective randomized clinical trial. Hum Reprod. 2002;17(11):2885-2890. https://doi.org/10.1093/humrep/17.11.2885
Katz-Jaffe M, Parks J, McReynolds S, Henry L, Schoolcraft W. Chromosomal mosaicism is impacted by compromised embryo culture conditions. Fertil Steril. 2018;110(4):e431. https://doi.org/10.1016/j.fertnstert.2018.08.037
Swain JE. Controversies in ART: can the IVF laboratory influence preimplantation embryo aneuploidy? Reprod Biomed Online. 2019;39(4):599-607. https://doi.org/10.1016/j.rbmo.2019.06.009
Popovic M, Dhaenens L, Boel A, Menten B, Heindryckx B. Chromosomal mosaicism in human blastocysts: the ultimate diagnostic dilemma. Hum Reprod. 2020;26(3):313-334. Update. 15 de abril de. https://doi.org/10.1093/humupd/dmz050
Treff NR, Marin D. The «mosaic» embryo: misconceptions and misinterpretations in preimplantation genetic testing for aneuploidy. Fertil Steril. 2021;116(5):1205-1211. https://doi.org/10.1016/j.fertnstert.2021.06.027
McGillivray G, Rosenfeld JA, McKinlay Gardner RJ, Gillam LH. Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing. Prenat Diagn. 2012;32(4):389-395. https://doi.org/10.1002/pd.3849
Boivin J, Gameiro S. Evolution of psychology and counseling in infertility. Fertil Steril. 2015;104(2):251-259. https://doi.org/10.1016/j.fertnstert.2015.05.035
Kahraman S, Cetinkaya M, Yuksel B, Yesil M, Pirkevi Cetinkaya C. The birth of a baby with mosaicism resulting from a known mosaic embryo transfer: a case report. Hum Reprod. 2020;35(3):727-733. https://doi.org/10.1093/humrep/dez309
Schlade-Bartusiak K, Strong E, Zhu O, et al. Mosaic embryo transfer - first report of a live born with non-mosaic partial aneuploidy and uniparental disomy 15. FS Rep. 2022.
Coll L, Parriego M, Boada M, et al. Transition from blastomere to trophectoderm biopsy: comparing two preimplantation genetic testing for aneuploidies strategies. Zygote. 2018;26(3):191-198. https://doi.org/10.1017/s0967199418000084

Auteurs

Lluc Coll (L)

Reproductive Medicine Unit, Department of Obstetrics, Gynaecology and Reproduction, Dexeus Mujer, Dexeus University Hospital, Barcelona, Spain.

Mònica Parriego (M)

Reproductive Medicine Unit, Department of Obstetrics, Gynaecology and Reproduction, Dexeus Mujer, Dexeus University Hospital, Barcelona, Spain.

Gabriela Palacios (G)

Reproductive Medicine Unit, Department of Obstetrics, Gynaecology and Reproduction, Dexeus Mujer, Dexeus University Hospital, Barcelona, Spain.

Sandra Garcia (S)

Reproductive Medicine Unit, Department of Obstetrics, Gynaecology and Reproduction, Dexeus Mujer, Dexeus University Hospital, Barcelona, Spain.

Montserrat Boada (M)

Reproductive Medicine Unit, Department of Obstetrics, Gynaecology and Reproduction, Dexeus Mujer, Dexeus University Hospital, Barcelona, Spain.

Buenaventura Coroleu (B)

Reproductive Medicine Unit, Department of Obstetrics, Gynaecology and Reproduction, Dexeus Mujer, Dexeus University Hospital, Barcelona, Spain.

Nikolaos P Polyzos (NP)

Reproductive Medicine Unit, Department of Obstetrics, Gynaecology and Reproduction, Dexeus Mujer, Dexeus University Hospital, Barcelona, Spain.
Faculty of Medicine and Health Sciences, Ghent University (UZ Gent), Gent, Belgium.

Francesca Vidal (F)

Unitat de Biologia Cel·lular, Facultat de Biociències, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Anna Veiga (A)

Stem Cell Bank, Centre of Regenerative Medicine in Barcelona, L'Hospitalet de Llobregat, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH